|
Position |
Director of Oncology Dept. |
Education |
|
Language |
|
No. of Operation |
N/A |
Publications |
- Wang CH, Chang FY, Chao TY, Kao WY, Ho CL, Chen YC, Dai MS, Chang PY, Wu YY, Lin JC. Characteristics comparisons of bacteremia in allogeneic and autologous hematopoietic stem cell-transplant recipients with levofloxacin prophylaxis and influence on resistant bacteria emergence. J Microbiol Immunol Infect. 2016 Mar 17. pii: S1684-1182(16)30003-2.
- Lee YC1, Ho CL2,Kao WY3, Chen YM4. A phase I multicenter study of antroquinonol in patients with metastatic non-small-cell lung cancer who have received at least two prior systemic treatment regimens, including one platinum-based chemotherapy regimen. Mol Clin Oncol. 2015 Nov;3(6):1375-1380.
- Lu CS1,Kao WY, Lin JC, Chang PY. Interferon-alpha caused reversible parkinsonism. Clin Neuropharmacol. 2015 May-Jun;38(3):119-20.
- Yeh RH, Yu JC, Chu CH, Ho CL, Kao HW, Liao GS, Chen HW, Kao WY, Yu CP, Chao TY, Dai MS. Distinct MR Imaging Features of Triple-Negative Breast Cancer with Brain Metastasis.J Neuroimaging. 2015 May;25(3):474-81.
- Huang TC, Chen JH, Wu YY, Chang PY, Dai MS, Chao TY,Kao WY, Chen YC, Ho CL. The treatment outcome of multiple myeloma patients ineligible for hematopoietic transplantation--a single institutional experience in Taiwan. Ann Hematol. 2015 Jan;94(1):107-15.
|
Update:2016/10/19 |
|